1. Home
  2. ACR vs CRBU Comparison

ACR vs CRBU Comparison

Compare ACR & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACR

ACRES Commercial Realty Corp.

HOLD

Current Price

$9.97

Market Cap

146.1M

Sector

Real Estate

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$0.46

Market Cap

138.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACR
CRBU
Founded
2005
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.1M
138.3M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
ACR
CRBU
Price
$9.97
$0.46
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $5.75
AVG Volume (30 Days)
53.7K
★ 4.1M
Earning Date
10-28-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 3.64
EPS
N/A
★ N/A
Revenue
★ $79,946,000.00
N/A
Revenue This Year
N/A
$145.34
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$9.92
$0.44
52 Week High
$24.61
$3.53

Technical Indicators

Market Signals
Indicator
ACR
CRBU
Relative Strength Index (RSI) 26.46 12.76
Support Level $9.92 N/A
Resistance Level $14.97 $1.73
Average True Range (ATR) 0.47 0.06
MACD 0.06 -0.07
Stochastic Oscillator 4.99 1.55

Price Performance

Historical Comparison
ACR
CRBU

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding, and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralized debt obligations, and private equity investments mainly issued by financial institutions.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: